PGEN Precigen, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 4, 2026
$8.54
· of 52w range
· above low
· to high
$2.9952w low
$8.9852w high
Market Cap (MRQ)
$3.06B
P/E
-6.3
EPS
$-1.37
Revenue
$10M
your badges
52W Range
$3–$9
Analyst Rating
BUY
Price Target
$14
P/E
-6.3
ROE
3159.1%
Net Profit Margin
-2588.2%
Your badge strip is empty — pin a metric anywhere on this page.
PGEN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.54
Market Cap (MRQ)
$3.06B
P/E
-6.3
EPS
$-1.37
Revenue
$10M
ROE
3159.1%
Debt/Equity (MRQ)
2.2
52W Range
$3–$9
PGEN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Precigen, Inc. - Common Stock Company overview from Wikipedia
Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.
## History
In 2015, Intrexon purchased Oxitec, a maker of genetically sterile insects, for $160 million. In April 2019, Intrexon formed a subsidiary called Precigen, with a focus on human gene therapy. Precigen went on to win orphan drug status from the FDA for a CAR-T based therapy (investigational drug name PRGN-3006) to treat acute myeloid leukemia. In early 2020, Intrexon adopted the name of its subsidiary, Precigen, and narrowed its focus to human gene editing. With the change in name the CEO of subsidiary Precigen, Helen Sabzevari, took over leadership of the company from Randal J. Kirk.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealthcare
industryBiotechnology
employees160
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$10M2016-12-31 → 2025-12-31
EPS$-1.372019-12-31 → 2025-12-31
Free Cash Flow$-90M2016-12-31 → 2025-12-31
Net margin-2588.2%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PGEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -6.35Y avg ≈-1.2 | ≈-1.2 | · | · | |
| P/S | 313.95Y avg ≈72.8 | ≈72.8 | 33.5 | Overvalued | |
| P/B (MRQ) | 70.25Y avg ≈26.8 | ≈26.8 | 4.5 | Overvalued | |
| EV / EBITDA | -28.35Y avg ≈25.0 | ≈25.0 | · | · | |
| Price / FCF (TTM) | -26.55Y avg ≈-11.1 | ≈-11.1 | · | · | |
| Price / Cash Flow (TTM) | -26.85Y avg ≈-11.8 | ≈-11.8 | · | · | |
| EV / Revenue | 313.45Y avg ≈74.0 | ≈74.0 | · | · | |
| EV / FCF (TTM) | -27.05Y avg ≈-11.3 | ≈-11.3 | · | · | |
| Price / Tangible Book (MRQ) | 74.55Y avg ≈131.6 | ≈131.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PGEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -1141.1% | · | 12.3% | Top tier | |
| EBITDA Margin | -1108.1%5Y avg ≈-351.6% | ≈-351.6% | 12.3% | Top tier | |
| Pretax Margin | -2588.2%5Y avg ≈-992.9% | ≈-992.9% | 15.1% | Top tier | |
| Net Profit Margin | -2588.2%5Y avg ≈-857.2% | ≈-857.2% | 10.2% | Top tier | |
| ROA | -166.7%5Y avg ≈-61.4% | ≈-61.4% | -18.5% | Weak | |
| ROE | 3159.1%5Y avg ≈1034.3% | ≈1034.3% | -8.4% | Top tier | |
| ROIC | -96.9% | · | -31.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PGEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 2.25Y avg ≈2.2 | ≈2.2 | · | · | |
| Current Ratio (MRQ) | 4.65Y avg ≈3.0 | ≈3.0 | 6.5 | Low liquidity | |
| Quick Ratio (MRQ) | 3.85Y avg ≈2.5 | ≈2.5 | 6.1 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 2.25Y avg ≈2.1 | ≈2.1 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | PGEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 146.7%5Y avg ≈13.2% | ≈13.2% | · | · | |
| Revenue CAGR 3Y | -28.9%5Y avg ≈-35.3% | ≈-35.3% | · | · | |
| Revenue CAGR 5Y | -21.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PGEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.2 | ≈0.2 | 0.1 | Weak | |
| Receivables Turnover | 4.05Y avg ≈11.0 | ≈11.0 | 7.1 | Weak | |
| Revenue / Employee | ≈$60.5K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-66.6%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $0.05 | $-0.01 | 467.6% |
| March 31, 2026 | May 13, 2026 | $-0.02 | $-0.03 | 38.7% |
| Dec. 31, 2025 | $-0.07 | $-0.09 | 17.6% | |
| Sept. 30, 2025 | $-1.06 | $-0.10 | -993.9% | |
| June 30, 2025 | $-0.09 | $-0.08 | -6.8% | |
| March 31, 2025 | $-0.07 | $-0.08 | 14.2% | |
| Dec. 31, 2024 | $-0.06 | $-0.06 | -4.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | $6M | $27M | $14M | $32M | $91M | $151M | $231M | $191M | $174M | $72M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $33M | $38M | $41M | $11M | |
| R&D Expense | $41M | $53M | $49M | · | · | · | · | $405M | $143M | $112M | $147M | $59M | |
| SG&A Expense | $70M | $41M | $40M | · | · | · | · | $138M | $146M | $142M | $109M | $64M | |
| Operating Expenses | $120M | $139M | $106M | · | · | · | · | $666M | $369M | $316M | $320M | $142M | |
| Operating Income | $-111M | $-135M | $-100M | · | · | · | · | $-506M | $-138M | $-125M | $-147M | $-70M | |
| Interest Expense | · | · | · | · | · | · | · | $9M | $611.0K | $861.0K | $1M | $666.0K | |
| Other Non-op | $43.0K | $6M | $627.0K | · | · | · | · | $630.0K | $1M | $2M | $1M | $-168.0K | |
| Pretax Income | $-251M | $-128M | $-96M | $-80M | $-111M | $-105M | $-171M | $-396M | $-78M | $-194M | $-87M | $-86M | |
| Income Tax | $3.0K | $-2M | $-458.0K | $-189.0K | $-160.0K | $-82.0K | $-930.0K | $-15M | $2M | $-4M | $1M | $-103.0K | |
| Net Income | $-251M | $-126M | $-96M | $28M | $-92M | $-171M | $-322M | $-509M | $-117M | $-187M | $-84M | $-82M | |
| EPS (Basic) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | · | · | · | · | · | |
| EPS (Diluted) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | · | · | · | · | · | |
| Shares (Basic) | 312,980,562 | 267,727,426 | 244,536,221 | 200,360,821 | 197,759,900 | 167,065,539 | 154,138,774 | · | · | · | · | · | |
| Shares (Diluted) | 312,980,562 | 267,727,426 | 244,536,221 | 200,360,821 | 197,759,900 | 167,065,539 | 154,138,774 | · | · | · | · | · | |
| EBITDA | $-107M | · | · | $11M | $14M | $18M | $25M | $-472M | $-107M | $-101M | · | $-60M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $30M | $8M | $5M | $36M | $52M | $66M | $97M | $68M | $63M | $136M | $27M | |
| Short-term Investments | $68M | $68M | $55M | $51M | $72M | $48M | $9M | $120M | $6M | $175M | $103M | $88M | |
| Receivables | $4M | $926.0K | $902.0K | $978.0K | $1M | $16M | $21M | $21M | $20M | $22M | $25M | $15M | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $7M | $6M | $5M | $7M | $7M | $7M | $4M | |
| Current Assets | $115M | $102M | $69M | $118M | $157M | $149M | $235M | $285M | $154M | $315M | $324M | $175M | |
| PP&E (Net) | $14M | $14M | $7M | $7M | $9M | $35M | $44M | $87M | $113M | $65M | $43M | $38M | |
| PP&E (Gross) | $38M | $37M | $31M | $31M | $30M | $70M | $80M | $136M | $158M | $99M | $69M | $60M | |
| Accum. Depreciation | $24M | $23M | $24M | $23M | $21M | $35M | $36M | $49M | $46M | $34M | $26M | $22M | |
| Goodwill | $15M | $19M | $27M | $37M | $38M | $54M | $54M | $94M | $94M | $157M | $165M | $101M | |
| Intangibles | $3M | $4M | $41M | $44M | $52M | $65M | $68M | $89M | $233M | $226M | $248M | $66M | |
| Other Non-current Assets | $908.0K | $371.0K | $767.0K | $1M | $936.0K | $2M | $1M | $2M | $4M | $4M | $4M | $1M | |
| Total Assets | $156M | $145M | $151M | $216M | $360M | $315M | $456M | $716M | $847M | $949M | $982M | $576M | |
| Accounts Payable | $12M | $4M | $2M | $4M | $3M | $5M | $6M | $12M | $9M | $8M | $5M | $6M | |
| Short-term Debt | · | · | $0 | $43M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $37M | $22M | $23M | $79M | $35M | $42M | $123M | $62M | $80M | $95M | $76M | $47M | |
| Capital Leases | $4M | $5M | $6M | $7M | $9M | $8M | $10M | $0 | · | · | · | · | |
| Deferred Tax | · | $0 | $2M | $2M | $3M | $3M | $3M | $4M | $16M | $17M | $22M | $0 | |
| Other Non-current Liabilities | $134.0K | $0 | · | · | $50.0K | $100.0K | $0 | $3M | $3M | $4M | $795.0K | $699.0K | |
| Total Liabilities | $135M | $79M | $33M | $90M | $253M | $247M | $384M | $337M | $300M | $380M | $277M | $167M | |
| Long-term Debt | $93M | $0 | · | $43M | $180M | $172M | $218M | $212M | $8M | $8M | $9M | $10M | |
| Total Debt | $93M | · | · | $43M | $183M | $172M | $218M | $212M | $8M | $8M | · | $10M | |
| Paid-in Capital | $2.36B | $2.13B | $2.08B | $2.00B | $2.02B | $1.89B | $1.75B | $1.72B | $1.40B | $1.33B | $1.25B | $843M | |
| Retained Earnings | $-2.34B | $-2.09B | $-1.96B | $-1.87B | $-1.92B | $-1.82B | $-1.65B | $-1.33B | $-848M | $-729M | $-543M | $-458M | |
| AOCI | $7.0K | $12.0K | $-2M | $-3M | $203.0K | $4M | $-27M | $-29M | $-16M | $-36M | $-13M | $-4.0K | |
| Stockholders' Equity | $21M | $39M | $118M | $126M | $107M | $67M | $72M | $363M | $534M | $560M | $694M | $385M | |
| Liabilities + Equity | $156M | $145M | $151M | $216M | $360M | $315M | $456M | $716M | $847M | $949M | $982M | $576M | |
| Shares Outstanding | 353,910,926 | 292,869,097 | 248,919,096 | 208,150,021 | 206,739,874 | 187,663,207 | 163,274,880 | 160,020,466 | 122,087,040 | 118,688,770 | 116,658,886 | 100,557,932 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $5M | $7M | $11M | $14M | $18M | $25M | $33M | $31M | $25M | $18M | $10M | |
| Stock-based Comp | $11M | $9M | $10M | $10M | $14M | $18M | $19M | $36M | $42M | $42M | $39M | $22M | |
| Deferred Tax | $0 | $-2M | $-479.0K | $-150.0K | $-167.0K | $-156.0K | $-4M | $-21M | $-3M | $-3M | $1M | $0 | |
| Amort. of Intangibles | $1M | $3M | $5M | $5M | $5M | $5M | $8M | $12M | $11M | $15M | $10M | $4M | |
| Other Non-cash | $149M | · | · | $-114M | $9M | $58M | $146M | $337M | $-57M | $67M | · | $30M | |
| Operating Cash Flow | $-88M | $-68M | $-67M | $-65M | $-56M | $-77M | $-136M | $-124M | $-104M | $-49M | $36M | $-20M | |
| CapEx | $2M | $9M | $2M | $5M | $7M | $8M | $38M | $42M | $47M | $32M | $13M | $6M | |
| Investing Cash Flow | $-2M | $-21M | $-3M | $226M | $-75M | $28M | $87M | $-151M | $104M | $-28M | $-259M | $-26M | |
| Debt Issued | $93M | $0 | $0 | · | $0 | $0 | $376.0K | $220M | $325.0K | $547.0K | $81.0K | $268.0K | |
| Net Debt Issued | $93M | · | · | $-155M | $-466.0K | $-490.0K | $-242.0K | $219M | $-194.0K | $-654.0K | · | $-379.0K | |
| Stock Issued | $-355.0K | $31M | $73M | $0 | · | · | · | · | $0 | $0 | $328M | $0 | |
| Net Stock Activity | $-355.0K | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $90M | $111M | $30M | $-155M | $121M | $33M | $8M | $310M | $4M | $12M | $332M | $24M | |
| Net Change in Cash | $717.0K | $22M | $-41M | $5M | $-9M | $-16M | $-42M | $35M | $6M | $-66M | $108M | $-22M | |
| Free Cash Flow | $-90M | · | · | $-70M | $-63M | $-85M | $-174M | $-166M | $-151M | $-88M | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | $-174M | $-151M | $-88M | · | $-27M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1141.1% | · | · | · | · | · | · | · | -59.7% | -65.6% | · | -97.3% | |
| Net Margin | -2588.2% | · | · | 105.2% | -88.7% | -165.3% | · | · | -50.7% | -97.7% | · | -113.8% | |
| Pretax Margin | -2588.2% | · | · | -297.2% | -93.3% | -100.7% | · | · | -56.1% | -101.7% | · | -119.2% | |
| EBITDA Margin | -1108.1% | · | · | 40.0% | 13.2% | 17.0% | · | · | -46.2% | -52.7% | · | -82.8% | |
| ROA | -166.7% | · | · | 9.8% | -27.3% | -44.3% | -55.0% | -65.2% | -13.0% | -19.3% | · | -15.7% | |
| ROE | 3159.1% | · | · | 21.1% | -77.3% | -271.3% | -148.3% | -113.6% | -21.4% | -29.8% | · | -21.8% | |
| ROIC | -96.9% | · | · | · | · | · | · | -84.5% | -24.9% | -21.6% | · | -17.7% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | · | 1.5 | 4.5 | 3.5 | 1.9 | 4.6 | 1.9 | 3.3 | · | 3.7 | |
| Quick Ratio | 2.7 | · | · | 0.7 | 3.9 | 2.8 | 0.8 | 4.0 | 1.2 | 2.7 | · | 2.7 | |
| Debt / Equity | 4.5 | · | · | 0.3 | 1.7 | 2.6 | 3.0 | 0.6 | 0.0 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 4.5 | · | · | 0.0 | 1.7 | 2.6 | 2.6 | 0.6 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | -59.3 | -225.7 | -145.4 | · | -105.0 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.3 | 0.3 | · | · | 0.3 | 0.2 | · | 0.1 | |
| Receivables Turnover | 4.0 | · | · | 23.4 | 5.6 | 5.6 | · | · | 11.2 | 8.2 | · | 9.4 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.06 | · | · | $0.61 | $0.52 | $0.36 | $0.44 | $2.27 | $4.37 | $4.72 | · | $3.83 | |
| Revenue / Share | $0.03 | · | · | $0.13 | $0.53 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.28 | · | · | $-0.32 | $-0.28 | · | · | · | · | · | · | · | |
| Cash / Share | $0.09 | · | · | $0.02 | $0.21 | $0.28 | $0.40 | $0.64 | $0.56 | $0.53 | · | $0.27 | |
| EPS (TTM) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | $-1.54 | $-1.54 | $-1.54 | $-0.74 | $-0.84 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | -37.0% | -76.9% | 88.6% | -55.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -28.9% | -35.0% | -42.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -21.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $4M | $6M | $27M | $14M | $32M | $91M | $151M | $231M | $191M | $174M | $72M | |
| Net Income TTM | $-251M | $-126M | $-96M | $28M | $-92M | $-171M | $-322M | $-509M | $-117M | $-187M | $-84M | $-82M | |
| Market Cap | $1.48B | · | · | $316M | $767M | $1.91B | $895M | $1.05B | $1.41B | $2.86B | · | $2.65B | |
| Enterprise Value | $1.47B | · | · | $304M | $835M | $1.99B | $1.04B | $1.04B | $1.34B | $2.63B | · | $2.54B | |
| P/E | -3.1 | -2.4 | -3.4 | 10.9 | -7.9 | -10.0 | -2.6 | -4.2 | -7.5 | -15.6 | -40.4 | -31.3 | |
| P/S | 152.8 | · | · | 11.8 | 53.8 | 59.8 | 9.9 | 6.9 | 6.1 | 15.0 | · | 36.8 | |
| P/B | 70.7 | · | · | 2.5 | 7.1 | 28.5 | 12.5 | 2.9 | 2.6 | 5.1 | · | 6.9 | |
| P / Tangible Book | 592.5 | 8.0 | 6.5 | 7.0 | 43.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | -16.8 | · | · | -4.9 | -13.8 | -24.9 | -6.6 | -8.4 | -13.5 | -51.1 | · | -133.2 | |
| P / FCF | -16.5 | · | · | -4.5 | -12.2 | -22.6 | -5.1 | -6.3 | -9.3 | -32.6 | · | -100.9 | |
| EV / EBITDA | -13.7 | · | · | 28.2 | 60.7 | 113.4 | 41.7 | -2.2 | -12.6 | -26.1 | · | -42.7 | |
| EV / FCF | -16.4 | · | · | -4.3 | -13.3 | -23.5 | -6.0 | -6.2 | -8.9 | -30.0 | · | -96.8 | |
| EV / Revenue | 152.3 | · | · | 11.3 | 58.5 | 62.1 | 11.4 | 6.9 | 5.8 | 13.8 | · | 35.3 | |
| Earnings Yield | -32.8% | -42.0% | -29.1% | 9.2% | -12.7% | -10.0% | -38.1% | -23.5% | -13.4% | -6.4% | -2.5% | -3.2% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55M | $23M | · | · | $856.0K | $1M | · | · | · | · | · | · | $2M | $2M | · | $17M | |
| R&D Expense | $7M | $6M | · | · | $11M | $10M | · | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $22M | $21M | · | · | $16M | $12M | · | · | · | · | · | · | · | · | · | · | |
| Operating Expenses | $32M | $29M | · | · | $33M | $24M | · | · | · | · | · | · | · | · | · | · | |
| Operating Income | $23M | $-6M | · | · | $-32M | $-23M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $16.0K | $290.0K | · | · | $-31.0K | $7.0K | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $20M | $-8M | · | · | $-27M | $-54M | $-20M | $-24M | $-60M | $-24M | $-33M | $-20M | $-20M | $-23M | $-22M | $-8M | |
| Income Tax | $0 | $0 | $0 | $0 | $3.0K | $0 | $-87.0K | $12.0K | $-2M | $-29.0K | $-332.0K | $-6.0K | $-65.0K | $-55.0K | $8.0K | $-50.0K | |
| Net Income | $20M | $-8M | $-24M | $-146M | $-27M | $-54M | $-20M | $-24M | $-59M | $-24M | $-33M | $-20M | $-20M | $-23M | $-22M | $87M | |
| EPS (Basic) | $0.06 | $-0.02 | $-0.04 | $-1.06 | $-0.09 | $-0.18 | $-0.05 | $-0.09 | $-0.23 | $-0.10 | $-0.13 | $-0.08 | $-0.08 | $-0.10 | $-0.11 | $0.44 | |
| EPS (Diluted) | $0.05 | $-0.02 | $-0.04 | $-1.06 | $-0.09 | $-0.18 | $-0.05 | $-0.09 | $-0.23 | $-0.10 | $-0.13 | $-0.08 | $-0.08 | $-0.10 | $-0.11 | $0.44 | |
| Shares (Basic) | 356,893,568 | 354,291,007 | · | 307,170,490 | 296,434,726 | 293,879,653 | · | 275,881,170 | 252,366,533 | 249,220,335 | · | 248,520,724 | 248,003,322 | 229,770,381 | · | 200,670,590 | |
| Shares (Diluted) | 413,686,865 | 354,291,007 | · | 307,170,490 | 296,434,726 | 293,879,653 | · | 275,881,170 | 252,366,533 | 249,220,335 | · | 248,520,724 | 248,003,322 | 229,770,381 | · | 200,670,590 | |
| EBITDA | $23M | $-5M | · | · | · | $629.0K | · | · | · | $2M | · | · | · | $2M | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $7M | $30M | $14M | $14M | $6M | $30M | $25M | $9M | $17M | · | $10M | $17M | $10M | · | $9M | |
| Short-term Investments | $22M | $49M | $68M | $107M | $46M | $74M | $68M | $4M | $10M | $27M | · | $64M | $72M | $94M | · | $62M | |
| Receivables | $72M | $26M | $4M | $580.0K | $327.0K | $751.0K | $926.0K | $479.0K | $511.0K | $872.0K | · | $988.0K | $1M | $2M | · | $1M | |
| Prepaid Expense | $4M | $4M | $3M | $4M | $2M | $3M | $3M | $5M | $3M | $4M | · | $5M | $3M | $4M | · | $6M | |
| Current Assets | $134M | $102M | $115M | $130M | $63M | $85M | $102M | $35M | $24M | $50M | · | $93M | $106M | $138M | · | $163M | |
| PP&E (Net) | $13M | $13M | $14M | $15M | $15M | $15M | $14M | $14M | $13M | $13M | · | $7M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $38M | $38M | $38M | $38M | $37M | $38M | $37M | $36M | $36M | $37M | · | $31M | $31M | $31M | · | $30M | |
| Accum. Depreciation | $25M | $25M | $24M | $23M | $23M | $23M | $23M | $23M | $22M | $25M | · | $24M | $24M | $24M | · | $23M | |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $19M | $19M | $25M | $25M | $27M | $27M | $37M | $37M | $37M | $37M | $37M | |
| Intangibles | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $39M | · | $40M | $43M | $44M | · | $42M | |
| Other Non-current Assets | $708.0K | $782.0K | $908.0K | $753.0K | $590.0K | $427.0K | $371.0K | $425.0K | $435.0K | $751.0K | · | $797.0K | $949.0K | $1M | · | $871.0K | |
| Total Assets | $170M | $139M | $156M | $171M | $102M | $129M | $145M | $83M | $73M | $135M | · | $191M | $208M | $242M | · | $259M | |
| Accounts Payable | $5M | $3M | $12M | $6M | $4M | $3M | $4M | $4M | $5M | $5M | · | $2M | $3M | $4M | · | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $14M | · | · | |
| Current Liabilities | $29M | $21M | $37M | $32M | $23M | $24M | $22M | $21M | $23M | $29M | · | $33M | $31M | $47M | · | $105M | |
| Capital Leases | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | · | $6M | $7M | $7M | · | $8M | |
| Deferred Tax | · | · | · | · | · | · | · | $89.0K | $77.0K | $2M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $77.0K | $106.0K | $134.0K | $163.0K | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $127M | $118M | $135M | $129M | $108M | $113M | $79M | $28M | $30M | $38M | · | $43M | $41M | $57M | · | $117M | |
| Long-term Debt | $94M | $94M | $93M | $93M | · | · | $0 | · | · | · | · | · | · | · | · | $82M | |
| Total Debt | $94M | $94M | · | · | · | · | · | · | · | · | · | $0 | $0 | $14M | · | $82M | |
| Paid-in Capital | $2.37B | $2.37B | $2.36B | $2.36B | $2.13B | $2.13B | $2.13B | $2.13B | $2.09B | $2.09B | · | $2.08B | $2.08B | $2.08B | · | $2.00B | |
| Retained Earnings | $-2.33B | $-2.35B | $-2.34B | $-2.32B | $-2.17B | $-2.14B | $-2.09B | $-2.07B | $-2.05B | $-1.99B | · | $-1.93B | $-1.91B | $-1.89B | · | $-1.85B | |
| AOCI | $-29.0K | $-17.0K | $7.0K | $24.0K | $11.0K | $12.0K | $12.0K | $13.0K | $-3M | $-3M | · | $-4M | $-3M | $-3M | · | $-7M | |
| Stockholders' Equity | $44M | $20M | $21M | $42M | $-37M | $-14M | $39M | $55M | $43M | $97M | $118M | $148M | $166M | $184M | $126M | $143M | |
| Liabilities + Equity | $170M | $139M | $156M | $171M | $102M | $129M | $145M | $83M | $73M | $135M | · | $191M | $208M | $242M | · | $259M | |
| Shares Outstanding | 358,008,798 | 355,903,977 | 353,910,926 | 353,810,556 | 297,846,160 | 295,135,060 | 292,869,097 | 292,869,097 | 252,656,151 | 250,248,808 | 248,919,096 | 256,398,527 | 255,482,753 | 255,482,753 | 208,150,021 | 208,150,021 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $803.0K | $630.0K | $629.0K | $661.0K | $674.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Stock-based Comp | $4M | $3M | $2M | $4M | $2M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $-89.0K | $12.0K | $-2M | $-29.0K | $-353.0K | $-13.0K | $-58.0K | $-55.0K | $12.0K | $-50.0K | |
| Amort. of Intangibles | $319.0K | $318.0K | $318.0K | $318.0K | $318.0K | $319.0K | $318.0K | $318.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-cash | · | $-40M | · | · | · | $35M | · | · | · | $6M | · | · | · | $-441.0K | · | · | |
| Operating Cash Flow | $-18M | $-44M | $-23M | $-29M | $-19M | $-16M | $-8M | $-23M | $-23M | $-14M | $-16M | $-17M | $-16M | $-18M | $-15M | $-24M | |
| CapEx | $392.0K | $258.0K | $18.0K | $389.0K | $966.0K | $622.0K | $1M | $882.0K | $2M | $4M | $1M | $236.0K | $101.0K | $154.0K | $53.0K | $2M | |
| Investing Cash Flow | $27M | $21M | $40M | $-63M | $28M | $-6M | $-65M | $6M | $15M | $24M | $13M | $11M | $24M | $-50M | $11M | $182M | |
| Debt Issued | · | · | $-654.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-29M | · | · | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $-355.0K | $-596.0K | $32M | $0 | $0 | $0 | $0 | $-693.0K | $74M | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-355.0K | · | · | · | $0 | · | · | · | $74M | · | · | |
| Financing Cash Flow | $-33.0K | $109.0K | $-514.0K | $93M | $-2M | $-679.0K | $78M | $32M | $52.0K | $0 | $0 | $0 | $-15M | $44M | $-39M | $-116M | |
| Net Change in Cash | $9M | $-23M | $16M | $562.0K | $8M | $-23M | $5M | $15M | $-8M | $10M | $-2M | $-7M | $-7M | $-25M | $-43M | $42M | |
| Free Cash Flow | · | $-44M | · | · | · | $-17M | · | · | · | $-18M | · | · | · | $-19M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.2% | -25.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | 36.5% | -34.1% | · | · | · | · | · | · | · | · | · | · | -1149.9% | -1228.2% | · | 522.5% | |
| Pretax Margin | 36.5% | -34.1% | · | · | · | · | · | · | · | · | · | · | -1153.6% | -1231.2% | · | -46.0% | |
| EBITDA Margin | 41.2% | -21.1% | · | · | · | · | · | · | · | · | · | · | · | 92.4% | · | · | |
| ROA | 14.8% | -5.9% | · | -114.9% | -30.4% | -41.1% | · | -17.5% | -41.9% | -12.6% | · | -8.8% | -7.7% | -7.9% | · | 27.5% | |
| ROE | 590.6% | -256.8% | · | -301.0% | -833.7% | -130.6% | · | -23.6% | -56.2% | -16.9% | · | -13.6% | -18.3% | -17.6% | · | 63.8% | |
| ROIC | 16.5% | -5.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.8 | · | 4.0 | 2.7 | 3.5 | · | 1.6 | 1.0 | 1.7 | · | 2.8 | 3.4 | 2.9 | · | 1.6 | |
| Quick Ratio | 3.8 | 3.9 | · | 3.8 | 2.6 | 3.4 | · | 1.4 | 0.9 | 1.6 | · | 2.3 | 2.9 | 2.3 | · | 0.7 | |
| Debt / Equity | 2.2 | 4.6 | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.1 | · | 0.6 | |
| LT Debt / Equity | 2.2 | 4.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.7 | · | · | · | · | · | · | · | · | · | · | 1.3 | 0.1 | · | 1.6 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $0.06 | · | $0.12 | $-0.12 | $-0.05 | · | $0.19 | $0.17 | $0.39 | · | $0.58 | $0.65 | $0.72 | · | $0.68 | |
| Revenue / Share | $0.13 | $0.07 | · | · | · | · | · | · | · | · | · | · | $0.01 | $0.01 | · | $0.08 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.06 | · | · | · | $-0.06 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.05 | $0.02 | · | $0.04 | $0.05 | $0.02 | · | $0.08 | $0.04 | $0.07 | · | $0.04 | $0.06 | $0.04 | · | $0.04 | |
| EPS (TTM) | $-1.07 | $-1.21 | · | $-1.38 | $-0.41 | $-0.55 | · | $-0.55 | $-0.54 | $-0.39 | · | $-0.37 | $0.15 | $0.14 | · | $0.12 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-158M | $-204M | · | $-247M | $-124M | $-157M | · | $-140M | $-135M | $-97M | · | $-85M | $22M | $25M | · | $25M | |
| Market Cap | $2.04B | $1.38B | · | $1.16B | $423M | $440M | · | $278M | $399M | $363M | · | $364M | $294M | $271M | · | $441M | |
| Enterprise Value | $2.10B | $1.41B | · | · | · | · | · | · | · | · | · | $290M | $205M | $181M | · | $452M | |
| P/E | -5.3 | -3.2 | · | -2.4 | -3.5 | -2.7 | · | -1.7 | -2.9 | -3.7 | · | -3.8 | 7.7 | 7.6 | · | 17.7 | |
| P/B | 46.8 | 68.1 | · | 27.8 | -11.5 | -31.3 | · | 5.0 | 9.2 | 3.7 | · | 2.5 | 1.8 | 1.5 | · | 3.1 | |
| P / Tangible Book | 79.1 | 643.9 | · | 50.3 | · | · | · | 10.8 | 30.3 | 11.4 | · | 5.2 | 3.4 | 2.6 | · | 7.0 | |
| P / Cash Flow | · | -31.4 | · | · | · | -26.9 | · | · | · | -25.8 | · | · | · | -14.7 | · | · | |
| Earnings Yield | -18.8% | -31.3% | · | -41.9% | -28.9% | -36.9% | · | -57.9% | -34.2% | -26.9% | · | -26.1% | 13.0% | 13.2% | · | 5.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $10M | $4M | $6M | $27M | $14M |
| Operating Margin % | -1141.1% | · | · | · | · |
| Net Income | $-251M | $-126M | $-96M | $28M | $-92M |
| Diluted EPS | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 4.5 | · | · | 0.3 | 1.7 |
| Current Ratio | 3.1 | · | · | 1.5 | 4.5 |
| Quick Ratio | 2.7 | · | · | 0.7 | 3.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-90M | · | · | $-70M | $-63M |
Institutional owners (13F) 235 filers · $868.3M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
235
Value held
$868.3M
New positions
40
Exited positions
26
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 40 (-10 vs prior Q) | 26 (+10 vs prior Q) | 89 (+18 vs prior Q) | 46 (-3 vs prior Q) | +8.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Patient Capital Management, LLC | $108,510,760 | 19,036,976 | 12.50% | Shares |
| BlackRock, Inc. | $97,737,450 | 17,146,921 | 11.26% | Shares |
| STATE STREET CORP | $68,414,051 | 12,002,465 | 7.88% | Shares |
| Diametric Capital, LP | $52,838,578 | 9,269,926 | 6.09% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $45,065,112 | 7,906,160 | 5.19% | Shares |
| VANGUARD GROUP INC | $43,804,109 | 10,479,452 | 5.04% | Shares |
| TANG CAPITAL MANAGEMENT LLC | $36,579,750 | 6,417,500 | 4.21% | Shares |
| Boxer Capital Management, LLC | $29,355,000 | 5,150,000 | 3.38% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $28,612,911 | 5,019,028 | 3.30% | Shares |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $22,982,189 | 4,031,963 | 2.65% | Shares |
| MORGAN STANLEY | $19,776,885 | 3,469,628 | 2.28% | Shares |
| Occam Crest Management LP | $19,652,378 | 3,605,941 | 2.26% | Shares |
| GOLDMAN SACHS GROUP INC | $19,416,797 | 3,406,456 | 2.24% | Shares |
| FMR LLC | $14,650,046 | 2,570,183 | 1.69% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12,603,680 | 2,211,172 | 1.45% | Shares |
| FIRST TRUST ADVISORS LP | $11,483,556 | 2,014,659 | 1.32% | Shares |
| BANK OF AMERICA CORP /DE/ | $10,535,960 | 1,848,414 | 1.21% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10,192,940 | 1,788,235 | 1.17% | Shares |
| NORTHERN TRUST CORP | $10,142,467 | 1,779,380 | 1.17% | Shares |
| Caption Management, LLC | $9,690,000 | 1,700,000 | 1.12% | Put option |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8,640,362 | 1,515,853 | 1.00% | Shares |
| Diametric Capital, LP | $8,048,400 | 1,412,000 | 0.93% | Call option |
| Woodline Partners LP | $7,991,087 | 1,401,945 | 0.92% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $7,386,904 | 1,295,948 | 0.85% | Shares |
| Point72 Asset Management, L.P. | $7,220,070 | 1,266,679 | 0.83% | Shares |
| FRANKLIN RESOURCES INC | $5,846,205 | 1,025,650 | 0.67% | Shares |
| BARCLAYS PLC | $5,308,799 | 931,368 | 0.61% | Shares |
| Caption Management, LLC | $5,130,000 | 900,000 | 0.59% | Shares |
| JPMORGAN CHASE & CO | $5,077,625 | 849,298 | 0.58% | Shares |
| PRELUDE CAPITAL MANAGEMENT, LLC | $5,028,922 | 882,267 | 0.58% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5,023,410 | 881,300 | 0.58% | Call option |
| CITADEL ADVISORS LLC | $4,676,217 | 820,389 | 0.54% | Shares |
| UBS Group AG | $4,438,949 | 778,763 | 0.51% | Shares |
| CITIGROUP INC | $4,131,856 | 724,887 | 0.48% | Shares |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $4,025,876 | 706,294 | 0.46% | Shares |
| Nuveen, LLC | $4,006,154 | 702,834 | 0.46% | Shares |
| GMT Capital Corp | $3,812,331 | 668,830 | 0.44% | Shares |
| LexAurum Advisors, LLC | $3,638,954 | 638,413 | 0.42% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $3,450,210 | 605,300 | 0.40% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,430,511 | 601,844 | 0.40% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $3,164,811 | 555,230 | 0.36% | Shares |
| RAYMOND JAMES FINANCIAL INC | $2,943,091 | 516,332 | 0.34% | Shares |
| CIBC Bancorp USA Inc. | $2,849,498 | 499,912 | 0.33% | Shares |
| Lansing Street Advisors | $2,823,905 | 495,422 | 0.33% | Shares |
| Bank of New York Mellon Corp | $2,704,635 | 474,497 | 0.31% | Shares |
| Swiss National Bank | $2,226,420 | 390,600 | 0.26% | Shares |
| Cetera Investment Advisers | $2,209,947 | 387,710 | 0.25% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $2,175,222 | 381,618 | 0.25% | Shares |
| PEAK6 LLC | $2,100,450 | 368,500 | 0.24% | Call option |
| Persistent Asset Partners Ltd | $2,027,872 | 355,767 | 0.23% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| RANDAL J. KIRK, R.J. KIRK DECLARATION OF TRUST, THIRD SECURITY, LLC ×21 filings | March 31, 2026 | 35.90% | Amendment | · | SEC |
| Jan. 6, 2020 | · | Initial filing | · | SEC | |
| Oct. 23, 2017 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 40 insiders · 16 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Helen Sabzevari | President and CEO | Aug. 23, 2026 M | 3,779,521 | 0 | 2 | $-2,562,794 |
| Harry Thomasian Jr. | Chief Financial Officer | Sept. 23, 2026 M | 311,914 | 0 | 4 | $-1,901,756 |
| Rick L. Sterling | Chief Financial Officer | Jan. 4, 2021 M | 340,020 | 0 | 0 | $0 |
| Rutul R Shah | Chief Operating Officer | Aug. 25, 2026 M | 468,865 | 0 | 6 | $-1,256,398 |
| Thomas Bostick | Chief Operating Officer | Jan. 4, 2020 M | 74,280 | 0 | 0 | $0 |
| Phil Tennant | Chief Commercial Officer | Aug. 25, 2026 M | 141,992 | 0 | 2 | $-725,731 |
| Donald P. Lehr | Chief Legal Officer | Aug. 23, 2026 M | 758,181 | 0 | 1 | $-127,011 |
| Jeffrey Thomas Perez | SVP, IP Affairs | Aug. 9, 2024 P | 743,097 | 0 | 0 | $0 |
| Bradford D. Osborne | VP, Finance and Accounting | April 21, 2021 A | · | 0 | 0 | $0 |
| Thomas D. Reed | Chief Science Officer | Jan. 4, 2020 M | 148,888 | 0 | 0 | $0 |
| Robert F. Walsh III | SVP, Energy & Fine Chem. | June 30, 2019 M | 28,816 | 0 | 0 | $0 |
| Nir Nimrodi | Chief Business Officer | Jan. 4, 2019 A | 19,482 | 0 | 0 | $0 |
| Joel D Liffman | SVP, Finance | Jan. 4, 2019 A | 99,315 | 0 | 0 | $0 |
| Kelly Huang | SVP-Consumer Sector | May 9, 2014 P | 3,200 | 0 | 0 | $0 |
| Thomas R. Kasser | SVP--Food Sector | May 9, 2014 P | 15,000 | 0 | 0 | $0 |
| Darryl Webster | SVP--Intellectual Property | March 20, 2014 A | 9,132 | 0 | 0 | $0 |
| Jeffrey B Kindler | Director | Aug. 26, 2026 S | 17,100 | 0 | 2 | $-2,231,145 |
| Nancy H Agee | Director | Aug. 21, 2026 P | 309,187 | 1 | 0 | $24,662 |
| RANDAL J. KIRK | Director | March 30, 2026 S | 12,262,741 | 0 | 25 | $-35,984,076 |
| Vinita D Gupta | Director | March 13, 2026 M | 666,027 | 0 | 0 | $0 |
| Steven Frank | Director | March 13, 2026 M | 1,226,391 | 0 | 0 | $0 |
| James S Turley | Director | March 13, 2026 M | 685,417 | 0 | 0 | $0 |
| Cesar L Alvarez | Director | March 13, 2026 M | 782,909 | 0 | 0 | $0 |
| Fred Hassan | Director | March 13, 2026 M | 1,243,239 | 0 | 0 | $0 |
| Dean J Mitchell | Director | March 14, 2024 A | 503,183 | 0 | 0 | $0 |
| Robert B Shapiro | Director | March 9, 2023 A | 329,656 | 0 | 0 | $0 |
| Trading S.A. Ares | 10% owner | Oct. 13, 2021 S | 20,647,152 | 0 | 0 | $0 |
| Andrew J. Last | · | Nov. 13, 2017 P | 4,000 | 0 | 0 | $0 |
| Geno J Germano | · | Sept. 22, 2016 A | · | 0 | 0 | $0 |
| Suma Krishnan | · | Jan. 29, 2016 M | 56,657 | 0 | 0 | $0 |
| Krish S Krishnan | · | Jan. 29, 2016 M | 56,657 | 0 | 0 | $0 |
| Ena Chan Cratsenburg | · | Jan. 7, 2016 A | · | 0 | 0 | $0 |
| INTREXON CORP | · | Jan. 7, 2016 A | · | 0 | 0 | $0 |
| Joseph L Vaillancourt | · | Oct. 19, 2015 A | · | 0 | 0 | $0 |
| Corey Huck | · | Oct. 12, 2015 A | · | 0 | 0 | $0 |
| Samuel Broder | · | July 21, 2015 A | · | 0 | 0 | $0 |
| Jack A Bobo | · | July 20, 2015 A | · | 0 | 0 | $0 |
| Olivier Roger Jarry | · | June 11, 2015 A | · | 0 | 0 | $0 |
| Gregory Ian Frost | · | May 28, 2015 M | 300,000 | 0 | 0 | $0 |
| HORNER LARRY D /FA | · | March 12, 2015 A | 68,507 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 29 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.94% | 304,977 NS | July 31, 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.74% | 1,539,558 NS | July 31, 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.62% | 17,299 SH | Oct. 2, 2026 | Daily |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.40% | 198,876 SH | Oct. 2, 2026 | Daily |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.35% | 765,206 NS | July 31, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.31% | 240,763 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.30% | 655,175 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.20% | 25,265 SH | Oct. 2, 2026 | Daily |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.15% | 139,467 NS | July 31, 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0.09% | 3,289 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.08% | 1,802,964 SH | Sept. 11, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.08% | 292,277 SH | Aug. 19, 2026 | Daily |
| IBB · iShares Trust | 0.08% | 1,205,825 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.06% | 206,995 SH | Aug. 19, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.04% | 49,171 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.04% | 4,946,547 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.04% | 92,222 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 1,111,545 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.02% | 585,833 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 92,500 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.02% | 22,110 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 10,765 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 2,042,450 SH | Aug. 19, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 62,200 SH | Sept. 9, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 286,766 SH | Sept. 11, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 5,690,796 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 14,522 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 8,008 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 25,549 SH | Sept. 11, 2026 | Daily |
PGEN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$12.00
+40.5%
2 22.2%
Strong Buy
5 55.6%
Buy
2 22.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-01Mean target $13.65 +59.8%
← Below all targets
Current price $8.54
Low$11.00
Mean$13.65
High$17.95
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 4, 2026